<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(8)</volume><submitter>Huang X</submitter><journal>BMJ open</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12336560</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report</pubmed_title><pmcid>PMC12336560</pmcid><pubmed_authors>Yu L</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Liao X</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-04-30T14:41:52.566Z</modification><creation>2026-04-07T16:03:38.504Z</creation></dates><accession>S-EPMC12336560</accession><cross_references/></HashMap>